Pfizer signs agreement to allow broader global access to its experimental Covid-19 antiviral pill

Submitted by mike kraft on

Pfizer signs license agreement to allow broader global access to its experimental Covid-19 antiviral pill Pfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill. Amanda Sealy, CNN CNN

...

The agreement with the Medicines Patent Pool, a United Nations-backed public health organization, would allow generic manufacturers to make the pill widely available in 95 low- and middle-income countries covering 53% of the world's population, the company said.
 
The pill, known as PF-07321332 or Paxlovid, is to be given in combination with an older antiviral drug called ritonavir. ...
 
ALSO SEE: Pfizer to conduct trials of antiviral COVID-19 pill in Russia
 
Country / Region Tags: 
United Nations
United States
General Topic Tags: 
Contagion
Disease
Health
Medical Testing
Pandemics
Policy
Public Health
Cooperation
Problem, Solution, SitRep, or ?: 
Situation Report
Groups this Group Post belongs to: 
- Private group -